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Background: This was a prospective single-center study to assess and analyze cerebral embolization resulting from carotid
artery stenting with neuroprotective filter devices in patients considered as poor surgical candidates for surgical carotid
endarterectomy.
Methods: Fifty-three consecutive patients with an internal carotid artery stenosis were treated by placement of carotid
Wallstents with two different types of temporary distal filter protection devices: the Spider filter and the FilterWire.
Diffusion-weighted magnetic resonance imaging (DWI) of the brain was obtained 24 hours before the procedure and
within 5 to 30 hours after the procedure to detect ischemic brain lesions resulting from the procedure. Inclusion criteria
were symptomatic (>70%) or asymptomatic (>80%) stenoses in surgical high-risk patients.
Results: Two (4%) regressive minor strokes occurred. Postprocedural DWI detected new focal ischemic lesions in 21
patients (40%). The average number of lesions was 5.9 per patient, and the mean lesion volume was 1 mL or less in 19
patients (90%). Small differences were found in the lesion distribution: homolateral anterior circulation in eight cases
(15.1%), other vascular territories in seven cases (13.2%), and homolateral anterior circulation plus other vascular
territories in six cases (11.3%). The microembolization risk seemed nonpredictable on the basis of clinical parameters and
internal carotid artery lesion characteristics. An increased risk in the rate of ipsilateral hemispheric embolization has been
observed in difficult carotid arch implantations (P  .04).
Conclusions: The incidence of new focal ischemic lesions detected by DWI is higher than expected on the basis of previous
reports. Embolization from the aortic arch or common carotid arteries could account for most of those events in patients
considered as surgical high-risk patients. Although 90% of the events were clinically silent, this high rate of microembo-
lization raises questions about the possible consequences on cerebral cognitive functions. ( J Vasc Surg 2005;42:847-53.)
Stent implantation for the treatment of extracranial
carotid artery stenosis has become an alternative to carotid
endarterectomy (CEA). During those procedures, emboli-
zation of air, thrombus, or plaque material can be respon-
sible for neurologic complications. Protection devices
placed distally to the lesion, before stent deployment and
balloon dilation, have been developed to minimize this
potential risk. The exact risk of embolization still remains
controversial and depends onmultiple factors. The purpose
of this prospective study was to determine the incidence of
new areas of cerebral ischemia by diffusion-weighted mag-
netic resonance imaging (DWI) in high-surgical-risk pa-
tients resulting from carotid artery stenting (CAS) and to
analyze the lesion distribution and the clinical and proce-
dural factors that could explain those events.
METHODS
Patient selection. This prospective study was started
in October 2002. The protocol was proposed to patients
with major cardiovascular risk factors and symptomatic
internal carotid artery (ICA) stenosis of 70% or more or
asymptomatic stenosis of 80% or more. One or more of the
following inclusion criteria had to be present: two or more
coronary vessels with 70% stenosis or more, ejection frac-
tion less than 30%, a New York Heart Association func-
tional class of III or higher, bronchopulmonary obstructive
disease, restenosis after a previous CEA, previous radical
neck surgery or radiation therapy, surgically inaccessible
lesions, and contralateral occlusion of the ICA.
Exclusion criteria were an evolving stroke or a recent
stroke within the previous 7 days, a transient ischemic
cerebral event within the last 24 hours, a history of allergic
reaction to any study medications or material, renal insuf-
ficiency (creatininemia 2 mg/dL), bilateral occlusions of
the iliac arteries or abdominal aorta, totally calcified ICA
stenoses, or suspicion of fresh thrombus at the level of the
ICA stenosis. Informed consent was obtained from each
patient.
Carotid artery imaging. All carotid lesions were de-
tected and imaged by color Doppler ultrasonography
(CDUS) with a ATL 5000 (Philips Medical Eindhoven,
The Netherlands) by using high-frequency probes. The
degree of stenosis was quantified on the basis of the peak
systolic velocity measured at the level of or immediately
after the stenosis (velocity 210 m/s, corresponding to
70% stenosis). Preprocedural diagnostic imaging of the
arch vessels and carotid stenosis by magnetic resonance
(MR) angiography was optional.
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Digital subtraction angiography (DSA) of the carotid
bifurcation, the intracranial portion of the ICA, and the
brain circulation was performed in all cases (Philips Integris
3000; matrix 1024  1024). Final quantification of the
ICA stenosis was performed according to the North Amer-
ican Symptomatic Carotid Endarterectomy Trial guide-
lines.1 The visualization or absence of visualization of the
anterior and posterior communicating arteries was de-
scribed, and flow direction was determined before and after
stenting. Contralateral common carotid artery (CCA) in-
jections were performed in patients requiring quantifica-
tion of bilateral lesions. In most patients, a global aortic
arch injection was performed (30° left anterior oblique
view) before selective carotid catheterization. A retrospec-
tive analysis of those DSA images allowed detection of
severe CCA angulations and quantification of the angle of
the CCA emergence with respect to the aortic arch. This
angle was measured at the intersection between a centerline
drawn through the first centimeters of the target CCA and
a line drawn between the anterior wall of the innominate
trunk and the posterior wall of the left subclavian artery, at
their ostial level. An angle less than 45° was considered to
be less favorable and technically more difficult for selective
catheterization and sheath placement.
Comparative review of the DSA and CDUS images
allowed description and classification of the carotid lesions
according to the lesion length (10 or10mm), presence
of ulcerations (0, nonulcerated; 1, 1 mm of ulceration; 2,
more than one ulceration or ulceration 2 mm), and
degree of calcification (0, homogenous and noncalcified; 1,
minimal calcification or 30% calcification; 2, more than
30% calcification).
MR imaging. All MR examinations were performed
on a 1.5-T MR system (Intera; Philips Medical) by using a
standardized protocol including a fast spin echo/fluid-
attenuated inversion recovery sequence (repetition time,
echo time, and inversion time of 1000, 120, and 2100
milliseconds, respectively; field of view, 230 mm) and an
echo planar imaging/spin-echo diffusion-weighted se-
quence (repetition time and echo time of 5110 and 84
milliseconds, respectively; field of view, 220 mm; matrix,
95  256) with and without application of diffusion-
sensitizing gradients in the three orthogonal directions,
performed at b 1000 s/mm2. A set of 24 axial transverse
images (5-mm thickness; 1-mm interslice gap) in similar
slice locations were obtained for both sequences. A baseline
MR examination was performed the day before the proce-
dure, and a follow-upMR study was performed on the same
day or the day after stent placement. Three trained neuro-
radiologists, blinded to clinical status and findings, inde-
pendently rated the diffusion-weighted trace images for the
absence or presence of acute ischemic parenchymal dam-
age. If positive, lesions were quantified by using the follow-
ing scoring system: number of lesions, location of lesions,
lesion sizes (categorized into lesions5 mm, 5-10 mm, or
10 mm), and total lesion volume (milliliters). Locations
were described to determine the vascular territories (ante-
rior or posterior circulation), the side (ipsilateral or con-
tralateral to the ICA stenosis), and the distribution (corti-
cal, subcortical, or deep areas). In addition, the baseline
preprocedural fluid-attenuated inversion recovery images
were reviewed to assess pre-existing chronic or subacute
infarcts and the degree of cerebral leukoaraiosis, which has
been evaluated according to a 0- to 9-point scale described
by Manolio and colleagues2 and Longstreth and associates,3
by using a template image and a text description.
Endovascular procedure and clinical assessment.
CAS was performed by two experienced interventionalists
(F.D.H. and R.V.), assisting each other. Two types of filters
were used: the FilterWire (EX and EZ) from Boston Scien-
tific (Maastricht, The Netherlands), composed of a perfo-
rated polyurethane membrane attached to a nitinol loop,
and the Spider filter (ev3 Inc, Paris, France), comprising a
nitinol basket. The outer diameters of the filter delivery
catheters were 3.9F, 3.5F, and 2.9F for the EX, EZ, and
Spider filters, respectively. The filter pores were less than
110 m. The Spider filter was mainly selected for large ICA
diameters because of the availability of larger devices (5-7
mm). After filter placement only, the ICA stenoses were
dilated (percutaneous transluminal angioplasty) before stent
deployment by using 3- or 3.5-mm-diameter monorail bal-
loons (Gazelle or Ultra-soft SV; Boston Scientific) in cases
judged to be to tight or tortuous, to allow primary passage of
the stent. Monorail 5F self-expandable carotid Wallstents
(Boston Scientific) were placed in all patients andwere chosen
according to the lesion’s length and the ICA and CCA diam-
eters, usually covering the external carotid artery. After de-
ployment, stents were always postdilated (4-6 mm). The
balloon was chosen according to the CDUS measurements;
the ICA diameter was never oversized beyond the stenosis.
Gross eye inspection of the filter determined the num-
ber and size of debris captured (0.5-1 mm or 1 mm).
Patients were premedicated with clopidogrel 75 mg/d
(Plavix, Sanofi-Synthelabo, Belgium), acetylsalicyclic acid
160 mg/d (Asaflow, Sandipro, Belgium) for at least 3 days
before the procedure. Clopidogrel (75 mg/d) was pre-
scribed for 2 months and was discontinued only in patients
scheduled for an operation, 10 days before the interven-
tion. Acetylsalicylic acid was not discontinued and was
prescribed for a lifetime. During the procedure, a bolus of
5000 U of heparin was administered, and additional hepa-
rin (up to 5000U) was injected, depending of the activated
clotting time (250-300 seconds). Per-procedure patient
monitoring and management was ensured by an anesthesi-
ologist. Puncture site closure devices were used in all cases
(Perclose and Angioseal), thus allowing noninterrupted
antiplatelet therapy.
An independent neurologist performed neurologic ex-
amination the day before the intervention and within 24
hours after the intervention. Clinical re-evaluation of the
patient and control CDUS were scheduled at 1 and 6
months and then annually.
Statistical analysis. Values are expressed as mean 
SD. For analysis of descriptive statistics and continuous and
categorical data, Pearson 2 or Fisher exact tests were used
as appropriate. A P value .05 was considered significant.
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All statistical analyses were performed with SPSS version
11.5 software (SPSS Inc, Chicago, Ill).
RESULTS
Between November 2002 and January 2005, 68 pa-
tients fulfilled the preliminary clinical and CDUS selection
criteria and were scheduled for angiography and possible
stenting. During DSA, 5 patients were excluded: CDUS
overestimation of the stenosis (n  2), severe tortuosity of
the CCA (n  1), and complete calcification of the ICA
lesions (n  2). In another patient the procedure was
attempted, but the protective filter could not be placed
because of an ICA kink. Protected CAS was successfully
performed in 62 patients (98.4%). DWI studies were ob-
tained in 53 patients. The reasons for missing MR imaging
(MRI) data were incomplete MRI studies (n  3) and
pacemakers contraindicating MRI (n  6).
Patient data and technical considerations. The
mean age of the 53 patients with DWI studies was 72.3 
9.2 years (range, 50-92 years). The male-female sex ratio
was 3:1. Atherosclerotic risk factors included a history of
tobacco smoking (59%), hypertension (89%), diabetes type
1 (2%), diabetes type 2 (38%), and treated dyslipidemia
(74%). Mild chronic renal insufficiency, defined as creatinine-
mia of 1.5 to 2 mg/dL, was found in six patients (11%).
Eighteen (34%) symptomatic carotid stenoses were
treated. In addition to systemic risk factors, the follow-
ing unfavorable conditions for surgery could be retained
in these patients: 50% to 70% contralateral ICA stenosis
(n  6), contralateral ICA occlusion (n  2), hostile
neck (n  1), and coronary artery bypass planned within
4 weeks (n  2).
The remaining 35 patients (66%) were asymptomatic
but presented tight ICA stenoses (80%) and the following
clinical situation: hostile necks (radical neck surgery and
radiotherapy, n 7), restenosis after CEA (n 2), surgical
failure of CEA (high cervical carotid bifurcation; n  1) in
29%, and a major operation planned (coronary bypass, n
14; aortic valve replacement, n  1; abdominal aortofem-
oral bypass, n  1) in 46% of the cases. Twelve asymptom-
atic patients (34%) had a contralateral ICA stenosis of more
than 50%, and three (9%) had a contralateral ICA occlusion.
The mean ICA stenosis rate was 87% 6%, and 58% of
the patients had stenosis graded as 90%. Carotid Wall-
stents were easily deployed in all cases except in one patient,
in whom the stent-covering membrane ruptured during
initiation of the deployment and necessitated retrieval of
the partially uncovered stent and placement of a new stent.
In one patient, two stents had to be used because of a severe
stenosis of the mid portion of the CCA associated with the
ICA stenosis. All patients had good improvement of the
ICA lumen, although minimal residual stenosis of 15% to
25% could be observed in six cases and 35% stenosis was
observed in one case.
The following protective filtering devices were used:
FilterWire (n 41) or Spider filter (n 12). Debris in the
protective filters (0.5-1.5mm)was found in 36 cases (68%).
Small fragments (1 mm) were found predominantly
(72%), and the average number of fragments was fewer than
3 in 44% of the cases, 3 to 6 in 25%, andmore than 6 in 31%.
The mean duration of the procedure, from the local anes-
thesia to access closure, including diagnostic angiography,
was 48  12 minutes.
Clinical results. No major systemic complications oc-
curred during the procedures or the first 30 days of follow-
up. One patient developed a puncture site hematoma,
which resolved spontaneously. No cardiac infarcts or deaths
were observed.
Neurologic events within 30 days were detected in two
cases (4%). Both patients belonged to the symptomatic group,
and the deficits were categorized as minor reversible strokes.
One patient presented with a quadrantanopsia, de-
tected 2 days after CAS. Three large lesions were found
with DWI in the left contralateral occipital lobe (ischemic
volume,4.7mL). Symptoms completely regressed within
10 days, and the visual field was normal 1 month after the
procedure. The second patient presented signs of confusion
and contralateral hemiparesis immediately after stent place-
ment and dilation. DWI detected multiples small lesions
(n  25; total volume, 2 mL) exclusively located in the
ipsilateral cerebral hemisphere; the largestmeasured 13mm in
diameter. The arm weakness resolved almost completely
within 3 weeks (nondisabling stroke). The functional
health index, by using the modified Rankin scale,4 was
categorized by the neurologist initially at 2 and one month
later at 1. At 1 year, the patient had completely recovered.
Patients were followed up by clinical and CDUS exam-
inations (1-24 months; median, 9 months). No patient
died or developed neurologic symptoms. Intrastent hyper-
plasia was found in 3 (5.7%) of 53 patients: 1 patient with a
50% stenosis, 1 with a 50% to 60% stenosis left untreated,
and 1 with an 80% stenosis that required additional balloon
dilation and stenting.
Results of DWI. Analysis of the baseline MRI studies
revealed white matter abnormalities in 50 (94%) of 53
patients. Leukoariosis was graded as mild (1-3) in 35
patients (70%) and as greater than 3 in 15 patients (30%).
Sequelae of previous infarcts were found in 15 patients
(28%). Focal subacute or acute DWI abnormalities were
detected before the CAS procedure in 10 patients (19%).
These findings confirm that a baseline study before the
procedure is mandatory.
Comparison between the DWI images acquired before
and after the stent procedure (mean delay, 19.3 hours) iden-
tified new ischemic brain lesions in 21 patients (39.6%). Ce-
rebral distribution of the lesions (Fig 1) according to t h e side
of the treated ICA stenosis into the homolateral anterior
circulation (HC), contralateral anterior circulation (CC),
and posterior circulation (PC) was as follows: HC, n  8,
HC plus CC, n 4; HC plus CC plus PC, n 1; HC plus
PC, n 1; CC, n 3; PC, n 3; and CC plus PC, n 1.
This means that eight patients (15%) had ipsilateral lesions,
six patients (11%) had lesions in the ipsilateral brain and
other vascular territories, and seven patients (13%) had
lesions in vascular territories that were not directly linked to
the treated vessel. These events could result from endovas-
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cular maneuvers in the aortic arch or the contralateral CCA,
from embolus migration through collateral pathways (oc-
cipitovertebral and ophthalmic anastomosis of the external
carotid artery), or through the circle of Willis.
On the angiograms, a functional anterior communicat-
ing artery with an ipsilateral to contralateral flow was visible
in nine cases. In only one of those patients, who also had a
contralateral ICA occlusion, DWI lesions were found in the
frontal contralateral brain; this definitively allowing us to
conclude an embolus migration through the anterior com-
municating artery. Anterior to posterior flow in the poste-
rior communicating artery, arising from the ipsilateral ICA,
was visible in 16 cases. In only one of them was a single PC
DWI lesion found. From these data, we can conclude that
most microembolization in the part of the brain other than
the ipsilateral hemisphere results predominantly, if not
exclusively, from endovascular maneuvers in the aortic arch
or from catheterization of other arch vessels.
The overall average number of lesions per patient with
positive DWI examinations was 5.9 (HC, 5.3; CC, 3.1; and
PC, 3.5). If 2 patients with massive microembolization (25
and 56 lesions) were excluded, this rate decreased to 2.2
(range, 1-6).The distribution of focal lesions into HC, CC,
and PC was 60%, 23%, and 17% and 46%, 32%, and 22%,
respectively, depending on whether the two patients were
included or excluded. Lesions were located in cortical
territories (62%), subcortical territories (34%), or deep
regions (4%). The diameter of the lesions was 10 mm or
smaller, and the total lesion volume was 1 mL or less (area
100mm2) in 19 (90%) of 21 patients (the 2 exceptions were
the patients who had minor strokes).
Statistical analysis. Although this finding was statisti-
cally nonsignificant, we could observe a slightly higher rate
of brain lesions in symptomatic patients, older patients,
patients with pre-existing leukoariosis, longer procedural
times, procedures performed with the FilterWire or with
balloon predilation, and stenoses with low calcification
(Tables I and II). We found a trend for contralateral
embolization in patients who underwent catheterization of
the opposite CCA (n 18) for diagnostic purposes: 33% vs
9.4%, respectively (P  .06).
The retrospective angiographic analysis of the CCA
implantations and tortuosities, which was possible for a
subgroup of 37 patients (similar positive DWI rate of
40.5%) who had had a global arch injection before selective
catheterization, seems to corroborate those findings. Four-
teen CCAs ipsilateral to the treated ICAs were categorized
as technically more challenging for selective catheterization
and subsequent sheath placement: 12 patients with a CCA-
arch angle of 45° or less plus 2 patients with severe angu-
lations of the proximal portion of the CCA (angle of 90°
and 103°). The risk of ipsilateral hemispheric lesions (HC
only) in those 14 patients was significantly higher com-
pared with that in the other 23 patients: 36% vs 5% (P 
.04; Fisher exact test).
Surprisingly, the incidence of ipsilateral brain lesions
was almost identical in the patients with empty filters and in
those in whom debris was retrieved (24% vs 28%). This
reinforces the impression that filters are effective in prevent-
ing embolic migration in most cases and that most embolic
events probably result from maneuvers in the aortic arch or
CCAs, before the filter is opened, and before the CAS
procedure itself.
DISCUSSION
DWI is themost powerful tool for the detection of focal
brain ischemia in the acute stage.5 It has been used for the
detection of cerebral embolism after acute ischemic neuro-
logic events and for the detection of silent ischemic brain
lesions after diagnostic cerebral angiography,6,7 coronary
bypass surgery,8 CEA,9-13 and stenting.14-18 The hyperin-
tense DWI lesions vanish over 2 weeks and may reappear as
hypointense sequelaes lesions thereafter.19 Optimal timing
of the DWI is therefore critical.
DWI of the brain has already been used in various
circumstances after surgical or endovascular procedures.
Fig 1. Distribution of the new focal cerebral ischemic lesions detected by diffusion-weighted magnetic resonance
imaging (DWI) into the homolateral (HC), contralateral (CC), and posterior (PC) circulation, according to the side
of the treated internal carotid artery.
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Cerebral diagnostic angiography by itself is associated with
an incidence of an estimated 9% of asymptomatic cerebral
infarctions.6 In the endovascular field, DWI has been ini-
tially used after unprotected CAS. Van Heesewijk et al15
found lesions in 15% and only in the ipsilateral hemisphere.
Jaeger et al16 published a rate of 29% of new ipsilateral
lesions and 9% of contralateral lesions in 20 (29.9%) of 67
patients, of whom only 1 had a neurologic deficit. The same
group published the first results with protected CAS.17
They found an incidence of 15%, but in this series of 20
patients only, high-grade ICA stenosis of more than 90%
was considered an exclusion criterion for the use of a filter
device. Finally, Schluter et al18 found new ischemic foci in
23% of his 42 patients treated by CAS with 6 different types
of cerebral protection devices. To our knowledge, there is
only 1 limited but recent study of 21 nonconsecutive patients;
it reports a higher rate of 43%, similar to our results. 20
Team experience, endovascular material, procedural
steps, medication (anticoagulation and antiaggregation),
and MRI parameters have been rigorous and standard-
ized as much as possible in our study, in accordance with
other protocols or guidelines, and are not able to explain
those high rates. Supporting this is our low neurologic
complication rate of 4%, which seems comparable to
results of CAS studies using protective filter devices in
high-surgical-risk patients.21,22 In addition, we have re-
cently applied an identical MRI and interpretation pro-
tocol (nonpublished data) in a limited number of surgi-
Table I. Analysis of potentially predictive factors for an increased risk of cerebral embolization during angiography
and the carotid artery stenting procedure
Variable No. Patients DWI positive DWI negative % Positive DWI P value
Symptomatic patients 18 9 9 50% NS
Asymptomatic 35 12 23 34%
Age 75 y 32 10 22 31% .1
Age 75 y 21 11 10 52%
Cerebral leukoariosis grade 3 31 11 20 35% NS
Cerebral leukoariosis grade 3 22 10 12 45%
Diabetic 22 8 14 36% NS
Nondiabetic 31 13 18 42%
Procedure time 50 min 30 10 20 33% NS
Procedure time 50 min 23 11 12 48%
Single CCA injection 13 4 9 31% NS
Arch and/or contralateral carotid DSA 40 17 23 43%
Contralateral stenosis (50%-100%) 23 9 14 39% NS
No contralateral stenosis 30 12 18 40%
Angiographic acquisitions 11 27 10 17 37% NS
Angiographic acquisitions 11 26 11 15 42%
DWI, Diffusion-weighted magnetic resonance imaging; NS, not significant; CCA, common carotid artery; DSA, digital subtraction angiography.
DWI was considered positive if at least 1 new lesion was found in the brain (total, 21 of 53 cases), independently from the localization (anterior or posterior
circulation). Statistical analysis was based on 2 and Fisher exact tests (nonsignificant, P  .05).
Table II. Analysis of factors that are theoretically able to increase the risk for embolization from the internal carotid
artery stenosis
Variable No. Patients DWI () ipsilateral DWI (	) ipsilateral % Positive DWI
Symptomatic patients 18 6 12 33%
Asymptomatic patients 35 8 27 23%
FilterWire 41 12 39 29%
Spider filter 12 2 10 17%
PTA before stent placement 18 6 12 33%
No PTA before stent placement 35 8 27 23%
Stenosis 70%-89% 22 5 17 23%
Severe stenosis 90% 31 9 22 29%
Stenosis length 10 mm 21 6 15 29%
Stenosis length 10 mm 32 8 24 25%
Nonulcerated stenosis 20 5 15 25%
Ulcerated stenosis grade 1-2 33 9 24 27%
Low plaque calcification (30%) 32 10 22 31%
High plaque calcification (30%) 21 4 17 19%
Debris in the basket 36 10 26 28%
No debris in the filter 17 4 13 24%
DWI, Diffusion-weighted magnetic resonance imaging; PTA, percutaneous transluminal angioplasty.
Only ipsilateral brain lesions were recorded (total, 14/53 cases).
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cal patients (18 low-risk patients, 78% of whom were
symptomatic; mean age, 70 years) treated by CEA and
found a low rate of silent embolizations (6%). This is in
accordance with most surgical studies,9-12 which have
found new lesions, located exclusively in the ipsilateral
hemisphere, in less than 12% of the cases and which tend
to demonstrate that our imaging and interpretation pro-
tocol was not too sensitive.
In conclusion, our study, which revealed new ischemic
lesions in 40% of patients, suggests that the microembolic
risk could have been underestimated, at least in some
subgroups of patients. Of interest is that in 13 (24.5%) of
the 53 patients, or 13 (62%) of the 21 positive DWI cases,
embolic lesions were found outside the vascular territory of
the treated ICA. Lesions in the contralateral hemisphere
could not be explained by collateral arterial pathways ex-
cept in one or two patients. On the basis of our data, the
main determinant for such microembolic events could be
the patient’s underlying diffuse atheromatosis or emboliza-
tion resulting mainly from the catheter, wire, or sheath
manipulation in the aortic arch and the CCAs. Great care
should therefore be taken, especially during the initial
phase of the procedure, before the filter placement and
CAS procedure itself. Contralateral CCA angiography
should be restricted as much as possible. Considering this,
a direct puncture technique of the CCA (excluding hostile
necks) to gain access to the targeted ICA could be a
valuable technique, at least for difficult carotid accesses, but
this would first require the development of an adequate
puncture site closure device.
Although the vast majority of those embolic events
(90%) did not induce evident neurologic deficits, the sig-
nificance of such clinically silent embolization during CAS
has not yet been established and should be a concern in an
elderly population, especially in patients with impaired brain
function or previous infarcts. A recent large population-based
study25 has shown that silent brain infarcts seen on DWI are
associatedwith a steeper decline in cognitive function andmay
be associated with dementia.23
Neuropsychometric deteriorations have definitively been
described after CEA24-27 and cardiac surgery.28 Those dete-
riorations, which may be definite or last for several months,
could be induced by microembolization, by transient brain
ischemia, or by postprocedural hyperperfusion. Data for
CAS are lacking, and it remains therefore not proven which
technique carries the highest risk for cognitive function
alteration. Therefore, we believe that besides other short-
or long-term issues, the potential consequences of micro-
embolization resulting from CAS still need to be clarified
by controlled and randomized studies before CAS can be
recommended as the primary treatment option for carotid
stenoses.
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INVITED COMMENTARY
Mark C. Myers, Richard J. Powell, MD, Lebanon, NH
Using diffusion-weighted magnetic resonance imaging (DWI),
Hammer et al have demonstrated an alarming rate (40%) of new
microinfarcts after filter-protected carotid artery stenting (CAS).
These data support previous studies that have demonstrated new
microinfarcts in 20% to 43% of patients after CAS.1,2 They are to be
commended on their overall results: there were only two (4%)
minor strokes that resolved completely, no myocardial infarctions,
and no deaths. The pattern of these cerebral infarcts suggests that
they are not due to failure of the embolic protection device.
Ipsilateral DWI infarcts occurred with equal frequency in cases
with and without visible debris captured in the filter. More impor-
tantly, the DWI lesions frequently involved the contralateral cere-
bral hemisphere, thus suggesting that many occurred before can-
nulation of the target carotid artery. The occurrence of these DWI
lesions seems, on the basis of Hammer and associates’ analysis, to
correlate with difficult arch anatomy, supra-aortic carotid torutu-
osity, and the performance of contralateral brachiocephalic selec-
tive catheterization. Thankfully, most of these lesions seem clini-
cally silent, but this would be better evaluated with formal
neuropsychiatric testing. These results argue against routine con-
traleral diagnostic arteriography as part of a CAS procedure, espe-
cially because one of the two strokes did occur in the contralateral
occipital lobe. In our center, like many, we are careful to minimize
manipulations in the aortic arch and attempt to cannulate only the
target carotid artery during CAS. Proper patient selection and
technical skill will be critical in decreasing CAS neurologic event
rates to those seen with carotid endarterectomy, especially in older
patient populations, in which CAS stroke and death rates have
exceeded 12%.3 We use computed tomographic angiography to
screen patients for difficult arch anatomy, evaluate aortic arch
plaque burden, and evaluate the carotid lesion length and calcifi-
cation. We have used this information to exclude some patients
from further consideration for CAS on the basis of anatomic
concerns. This study by Hammer et al supports the concepts that
minimal, focused catheter manipulation within the aortic arch and
careful patient selection based on evaluation of aortic arch/carotid
anatomy will limit the incidence of neurologic events during CAS.
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